Pharmacology, Toxicology and Pharmaceutical Science
Amikacin
14%
Aminoglycoside
14%
Antibiotic Resistance
100%
Antiinfective Agent
85%
Antimicrobial Resistance
100%
Antimicrobial Resistance Diagnostics
14%
Carbapenem
19%
Colistimethate
14%
Enterobacteriaceae
19%
Escherichia coli
38%
Extended Spectrum Beta Lactamase
19%
Gastroenterology
38%
Healthcare Associated Infection
19%
Hospital Infection
57%
Infection
61%
Infectious Agent
52%
Methicillin Resistant Staphylococcus Aureus Infection
19%
Methicillin-Resistant Staphylococcus Aureus
19%
Observational Study
14%
Pseudomonas aeruginosa
57%
Vancomycin-Resistant Enterococcus
38%
Medicine and Dentistry
Antibiotic Resistance
57%
Antiinfective Agent
38%
Antimicrobial Activity
19%
Carbapenem
19%
Enterobacteriaceae
19%
Enterococcal Infection
19%
Escherichia coli
38%
Extended Spectrum Beta Lactamase
19%
Gastroenterology
38%
Health Care Cost
19%
Healthcare Associated Infection
19%
Hospital Infection
57%
Infection
19%
Methicillin Resistant Staphylococcus Aureus
19%
Methicillin Resistant Staphylococcus Aureus Infection
19%
Nephrology
19%
Nose Smear
19%
Pathogen
38%
Urine Sampling
19%
Vancomycin Resistant Enterococcus
38%
Vascular Surgery
19%
Nursing and Health Professions
Antibiotic Resistance
57%
Antiinfective Agent
42%
Antimicrobial Resistance
57%
Carbapenem
14%
Enterococcal Infection
14%
Extended Spectrum Beta Lactamase
14%
Healthcare Associated Infection
14%
Hospital Infection
42%
Infection
14%
Intensive Care Unit
57%
Methicillin Resistant Staphylococcus Aureus Infection
14%
Methicillin-Resistant Staphylococcus Aureus
14%
Nose Smear
14%
Nutrition Policy
57%
Practice Guideline
14%
Urine Sampling
14%
Vancomycin-Resistant Enterococcus
28%
Vascular Surgery
14%